IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $823 | -84.0% | 20,915 | -91.3% | 0.01% | -90.5% |
| Q4 2022 | $5,134 | -98.5% | 239,776 | +1123.2% | 0.06% | +1475.0% |
| Q3 2022 | $352,000 | -77.1% | 19,603 | -87.8% | 0.00% | -75.0% |
| Q2 2022 | $1,540,000 | +172.1% | 160,074 | +376.0% | 0.02% | +300.0% |
| Q1 2022 | $566,000 | -5.5% | 33,630 | -6.2% | 0.00% | +33.3% |
| Q4 2021 | $599,000 | -40.3% | 35,843 | -42.0% | 0.00% | -40.0% |
| Q3 2021 | $1,004,000 | +89.1% | 61,804 | -28.0% | 0.01% | +66.7% |
| Q1 2021 | $531,000 | +391.7% | 85,857 | +447.4% | 0.00% | +200.0% |
| Q4 2020 | $108,000 | +1.9% | 15,684 | -24.5% | 0.00% | 0.0% |
| Q2 2020 | $106,000 | – | 20,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |